Clinical value of a new TSH binding inihibitory activity ass…
Established
69
Citations42
Refs2001
Year
Search Works
Work Details
- DOI 10.1046/j.1365-2265.2001.01197.x
- PMID https://pubmed.ncbi.nlm.nih.gov/11167931
- OpenAlex ID W2158378241
- Type Article
- Language EN
- Published 01 Jan 2001
- Volume 54 (1)
- Pages 89–96
- Source Clinical Endocrinology
- Publisher Wiley
- FWCI 3.62
- Countries 1
- Institutions 2
- Added 24 Jun 2016
- Updated 14 Oct 2026
External Links
MENU
0
Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow‐up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay
Article 2001 EN
First, to evaluate the performance level of a new TSH binding inhibitory antibody assay using human recombinant TSH receptors (h-TBII) in comparison with a thyroid stimulating antibody (TSAb) bioassay performed before, at the end of treatment (18 months) and after antithyroid drug withdrawal in Graves' disease patients; second, to assess the accuracy with which h-TBII levels could predict relapse…
69
Citations
42
References
2
Authors
3.62
FWCI
Citations by Year
Last 9 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
2 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Didier Maugendre Corresponding | Centre Hospitalier Universitai… (FR) | — |
| 2 | Catherine Massart | Hôpital Pontchaillou (FR) | — |
Related Works
10Data: OpenAlex